Optimizing SARS-CoV-2 Detection: A Rapid, Cost-Effective Reverse Transcription Polymerase Chain Reaction (RT-PCR)...

Area of Science:

• * Molecular Diagnostics
• * Virology
• * Infectious Disease Research

Background:

• * The COVID-19 pandemic necessitated rapid and reliable diagnostic methods for SARS-CoV-2 detection.
• * Conventional reverse transcription polymerase chain reaction (RT-PCR) is accurate but can be limited by RNA extraction reagent shortages and long processing times.
• * Alternative antigen tests have limitations in sensitivity.

Purpose of the Study:

• * To evaluate the diagnostic accuracy of the Tata MD CHECK RT-PCR XF kit, a direct RT-PCR assay.
• * To compare the performance of this direct RT-PCR method against conventional RT-PCR with RNA extraction for SARS-CoV-2 RNA detection.

Main Methods:

• * A cross-sectional study involving 110 nasopharyngeal and oropharyngeal samples.
• * Samples were tested using two methods: conventional RT-PCR with RNA extraction and direct RT-PCR (Tata MD CHECK RT-PCR XF) without RNA extraction.
• * Diagnostic accuracy metrics including sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated.

Main Results:

• * The direct RT-PCR assay demonstrated high diagnostic accuracy: 93.9% sensitivity, 100% specificity, 100% PPV, and 84.4% NPV.
• * Performance was comparable to conventional RT-PCR, particularly in lower viral load samples (Ct 0-30).
• * The direct method significantly reduced turnaround times and costs.

Conclusions:

• * The Tata MD CHECK RT-PCR XF kit is a highly accurate and efficient diagnostic tool for SARS-CoV-2.
• * Eliminating the RNA extraction step offers a cost-effective and rapid alternative for COVID-19 testing.
• * This direct RT-PCR approach can alleviate resource constraints during public health emergencies.